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Purpose/Objective: Be able to know the real dosimetry inside the 
patients is very important to know the accuracy provided by the 
Treatment Planning Systems (TPS) and at the same time it is very 
difficult to realize. To evaluate the dosimetry in a realistic manner 
without resorting to a real patient, anthropomorphic phantoms can be 
used. . In this work, we have evaluated the calculations provided by 
the TPS Eclipse V10 with AAA algorithm in the pelvic area of a RANDO 
Man© anthropomorphic phantom for prostate treatments, assessing 
the measures through the use of termoluminiscent detectors (TLDs) 
with the data provided by the planner in PTVs as well as in various 
organs of risk.  
Materials and Methods: 4 prostate treatments, 2 low risk cases (PTV-
T to 7000cGy in 30 fractions) and 2 high risk cases with nodal chain 
irradiation (PTV-T to 7000cGy and PTV-N to 5040 in 30 fraction)) were 
planned using a Eclipse V10 with AAA algorithm and irradiated in a 
VARIAN 2300 iX linear accelerator, equipped with Millenium 120 MLC. 
PTVs and OARs were delineated in the previously scanned phantom. 
All treatment plans consisted of a single VMAT field, 6 MV X-rays, full 
rotation and 30º of collimator rotation. Dose was prescribed to the 
median PTV dose, requiring that more than 98% of the PTV volume 
should receive at least 95% of the prescribed dose, and no more than 
2% of the PTV volume should exceed 107% of the prescribed dose. 
Organs at risk fulfilled the departments’ constraints. A set of 100 TLDs 
(Harshaw XD-100 extremity (EXT-RAD) model) was used in order to 
calibrate, background measures, and PTVs and Organs At Risk (OARs) 
measurements.  
Results: The results of the TLDs dose measurements are summarized 
in the Table 1.And the absolute desviations for all the measurements 
is presented in Figure 1.Regarding with the high dose low gradient 
region, the average dose difference was -1.5% ± 4.6% (1 SD) for the 
PTV-T and -0.3% ± 4.5% for the PTV-N. The average OARs dose 
difference is below 2.5% for all of them. The standard deviation of the 
OARs is significantly higher than the corresponding to the PTVs. A 
plausible explanation is that the TLD have a size of about 3 mm, and 
are located in regions of high dose gradients. Also must be taken into 
account that small variations of the TLD position have a great impact 
on its dose measurement or calculation. Although the analysis done in 
this work was focused on the prostate, it is equally applicable to the 
rest of pathologies involved in the pelvis or abdominal area, because 
the type of heterogeneities is quite similar. 
 
Table 1: Number of measurements for each location and mean
result in %  
Location Number ofmeasurements 
Mean result (Dcalculated -
Dread)/Dread 
Rectum 10 -0.22% ± 9.7% 
Bladder 4 2.35% ± 3.6% 
Femoral Heads 16 -2.02% ± 6.4% 
Intestinal 
package 2 0.99% ± 8.7% 
PTV-T 11 -1.50% ± 4.6% 
PTV-N 6 -0.27% ± 4.5% 
 
 Conclusions: The use of TLD in conjunction with anthropomorphic 
phantoms is a useful tool to verify the accuracy of the dose 
calculation algorithm implemented in the TPS in realistic anatomical 
cases. We conclude that the AAA algorithm provides reliable dose 
calculation for the treatment with VMAT in the anatomy of the pelvis. 
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Purpose/Objective: Step 1 : To validate relative and absolute dose 
calculations of electron Monte Carlo algorithm (Eclipse, eMC 10.0.28, 
Varian) in simple geometry conditions for a set of inserts (rectangle, 
square) used in the clinical routine in a water phantom: profiles, 
percentage depth dose (pdd) and monitor units (MU) calculations. 
Step 2 : To study some dosimetric parameters of eMC calculations for 
boost dose in breast cancer: 1) validation of relative dose and MU 
calculations with obliquities in a water phantom and 2) comparison of 
MU calculated in Step 1 with 13 patient case studies ; first, with mass 
densities of the patients ; second, by assigning 0 UH to the 'body' not 
to take into account internal heterogeneities.  
Materials and Methods: Varian eMC modelling procedure was carried 
out for 7 energies (6MeV, 9MeV, 12MeV, 15MeV,16MeV, 18 MeV and 
20MeV) and 5 applicators (6x6cm2, 10x10cm2, 15x15cm2, 20x20cm2 and 
25x25cm2). Cylindrical and flat ionisation chambers (CC13, PPC40, 
NACP – IBA Dosimetry) were used for relative and absolute dose 
measurements in water. MU were calculated for delivering 1 Gy at the 
maximum depth dose on the beam axis. eMC calculations grid size and 
accuracy were 2 mm and 1%. In step 1, the gantry was perpendicular 
to the water phantom and the surface skin distances were 100cm, 
105cm and 110cm. 
Results: Step 1 : Relative dose measurements including profiles in the 
lateral constriction of 80% isodose curve gave good agreements with 
eMC calculations. The largest differences in pdd at 50% of the 
maximum dose were found at 6 MeV, up to 2.1 mm for a 5x10cm2 
rectangular inlay. Profiles fitted well with differences < 1% of the 
inlay size at 50% of the profile. The largest differences were found 
after the flat floor of the profile on the rounded part (between 98% 
and 90%). We achieved good agreement between MU eMC calculations 
and measurements, resulting in a maximum absolute deviation of 
3.8%, 2.2% and 1.9% respectively for energies of 6MeV, 9MeV and 
12MeV. Step 2 : Differences between MU eMC calculations in patients 
and MU calculated in water in step 1 were slightly higher, resulting 
respectively to 9.2%, 3.5% and 23.3% in mean, minimum and maximum 
deviations. These deviations remained similar when assigning 0 UH to 
the 'body' of the patients, resulting respectively to 8.1%, 3.5%, and 
21.6%.  
Conclusions: Step 1 : Relative and absolute dose measurements were 
found to be accurate enough for a clinical use of eMC. Step 2: 
significant differences were identified between UM measurements in 
water (step 1) and eMC calculations in patients both with mass 
densities of the patients or by assigning 0 UH to the 'body'. Beam 
obliquity relative to the patient surface was found to be one of the 
main parameter that could explain this deviation (as far as 
prescription point was at the maximum pdd in a soft tissue).  
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Purpose/Objective: Independent verification of the monitor unit (MU) 
calculation for radiotherapy is important to ensure the accuracy of 
the dose calculation in the treatment planning system (TPS). In2011, 
task group 114 (TG-114) of the American Association of Physicists in 
Medicine published a report for use as a guideline for verifying the MU 
calculation. We consider the clinical use of an independent MU 
calculation software (EqualDose v 4.0) that was developed by a 
project of the European Society for Radiotherapy and Oncology. We 
have evaluated the accuracy of dose calculation by this MU calculation 
software on the basis of the TG-114 report. 
Materials and Methods: Verification plans in a homogeneous phantom 
were modeled in the TPS (Xio, Elakta Oncology Systems and 
Eclipse,Varian Medical Systems), including open, physical wedge, 
dynamic wedge, and multi-leaf collimator fields. We selected an 
evaluation point within the phantom at the isocenter and off-axis 
point. Superposition (SP), Convolution (CO), Clarkson (CL), Analytical 
Anisotropic Algorithm (AAA), and Pencil Beam Convolution (PBC) 
